Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Telix Pharmaceuticals Ltd
ASX:TLX
Telix Pharmaceuticals Ltd
ASX:TLX
Price on Oct 15:
15.065
AUD
Market Cap:
AU$5.1B
Prices of ASX stocks are not being updated. The latest TLX price on Alpha Spread is from Oct 15, 2026. Financials, forecasts and intrinsic value keep updating.
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
AU |
|
Telix Pharmaceuticals Ltd
F:T3X
|
AU |
|
T
|
Telix Pharmaceuticals Ltd
OTC:TLPPF
|
AU |
Wall St Price Targets
TLX Price Forecast
Based on 13 analysts
Based on 13 analysts
+49% Upside
from
AU$15.065
today
Telix Pharmaceuticals Ltd (TLX)’s 12-month stock price forecast through October 2027 has a consensus target of AU$22.44, implying 49% upside. The forecast is based on price targets from 13 Wall Street analysts.
TLX Analyst Rating
No ratings yet
No ratings yet
Telix Pharmaceuticals Ltd Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TLX's stock price target?
Price Target
22.44
AUD
22.44
AUD
According to Wall Street analysts, the average 1-year price target for TLX is 22.44 AUD with a low forecast of 18.988 AUD and a high forecast of 33.075 AUD.
What is the Revenue forecast for Telix Pharmaceuticals Ltd?
Projected CAGR
12%
12%
Over the last 7 years, the compound annual growth rate for Revenue has been 228%. The projected CAGR for the next 8 years is 12%.
What is the Gross Profit forecast for Telix Pharmaceuticals Ltd?
Projected CAGR
16%
16%
The compound annual growth rate for Gross Profit over the next 8 years is 16%.
What is the Operating Income forecast for Telix Pharmaceuticals Ltd?
Projected CAGR
41%
41%
The compound annual growth rate for Operating Income over the next 8 years is 41%.
